Serum Spexin Levels as a Biomarker for Hyperemesis Gravidarum: A Case-Control Study

dataset OA: green CC0

Abstract

Objective: To compare the outcomes between patients undergoing surgery for ruptured endometrioma versus non-ruptured endometrioma.Study Design: The study was conducted at Health Sciences University, Etlik Zübeyde Hanım Training and Research Hospital Infertility Clinic. All patients who had a histopathology report of endometrioma between January 2014 and December 2020 were recruited. Patient files, surgery notes and laboratory values were extracted from the electronic recording system and patients with ruptured endometriomas (RE) or non-ruptured endometriomas (NRE) were compared. Results: Overall, 181 patients were recruited to the study. No rupture was detected in 146 (80.7%) patients while 35 patients (19.3%) underwent surgery for RE. Pre-operative CRP, CA 125, CA 19-9, CA 15-3, CEA and mean platelet volume (MPV) values and postoperative MPV and neutrophil/lymphocyte ratio (NLR) values were statistically significantly higher (p<0.01) in the RE group compared to the NRE group. Post-operative lymphocyte (p=.029) and eosinophyl (p=.015) values were significantly lower in the RE group compared to the NRE group. Among the preoperative biomarkers that are evaluated for prediction of rupture; MPV, CA 19-9 and CA-15.3 had a high specifity (>75%) but a rather low sensitivity (<60%), meanwhile CRP, CA-125 and CEA had high sensitivity but a low specifity.Conclusion: RE patients had significantly higher preoperative CRP, CA 125, CA 19-9, CA 15-3, CEA, and MPV values and postoperative MPV and NLR values while postoperative, lymphocyte and eosinophyl values were significantly lower compared with the NRE patients. Prospective studies with larger sample sizes are needed to determine biomarkers and parameters that can be used for non-invasive diagnosis of endometriosis and predict the possibility of endometrioma rupture.
Full text 1,050 characters · extracted from oa-html · click to expand
Serum Spexin Levels as a Biomarker for Hyperemesis Gravidarum: A Case-Control Study Principal Investigator(s): View help for Principal Investigator(s) Alperen Aksan, Şar Hospital Version: View help for Version V1 | Name | File Type | Size | Last Modified | |---|---|---|---| | heg spexin spss 2-2.xlsx | application/vnd.openxmlformats-officedocument.spreadsheetml.sheet | 31.3 KB | 04/06/2025 01:22:PM | Project Citation: Project Description Related Publications Published Versions Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know. This material is distributed exactly as received from the data depositor. As of April 2026, depositors are required to submit study materials in accessible formats. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometriomainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T11:15:38.095774+00:00
License: CC0 · commercial use OK